Scholarlink

Objective <p>This study aimed to investigate the efficacy of repetitive transcranial magnetic stimulation (rTMS) for improving spasticity, motor function, and activities of daily living (ADL) in patients with post-stroke spasticity (PSS), and to perform a comprehensive analysis of key factors related to its therapeutic effect.</p> Methods <p>Relevant randomized controlled trials (RCTs) were retrieved from four databases. Meta-analysis was conducted using RevMan, and the quality of evidence was assessed with the GRADEpro tool.</p> Results <p>Overall, 13 studies (encompassing 18 RCTs) were included. The results demonstrated that rTMS alleviated PSS (MD = − 0.23, 95% CI: −0.43 to − 0.02, <i>P</i> = 0.03) and improved motor (MD = 2.46, 95% CI: 1.54 to 3.38, <i>P</i> &lt; 0.00001), whereas it showed no significant effect on ADL (SMD = 0.31, 95% CI: -0.06 to 0.67, <i>P</i> = 0.10). For spasticity, stimulating the unaffected hemisphere achieved significantly better efficacy (SMD = -0.19, 95% CI: -0.37 to -0.00, <i>P</i> = 0.05), and combined high and low frequency rTMS showed promising effects (SMD = -0.65, 95% CI: -0.94 to -0.36, <i>P</i> &lt; 0.00001). For motor function, rTMS yielded greater improvement in upper limb PSS patients (SMD = 3.58, 95% CI: 2.18 to 4.98, <i>P</i> &lt; 0.00001). Within a certain range, pulse number was positively correlated with motor improvement (β = 2.46, 95% CI: 0.097 to 4.81, <i>P</i> = 0.043).</p> Conclusion <p>Moderate to high quality evidence demonstrates that rTMS can potentially alleviate PSS and improve motor function in patients, whereas its efficacy in improving ADL remains unclear, with very low quality of evidence. In addition, stimulation frequency, stimulation site, pulse number, and affected site are key moderators of rTMS efficacy. These findings guide the clinical optimization of rTMS regimens, and future research is required to identify specific parameter thresholds.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy of repetitive transcranial magnetic stimulation for post-stroke spasticity: a meta-analysis of randomized controlled trials

  • 期刊论文

  • 发表日期：

    2026年7月3日

查看全文
  • Yage Wang,
  • Taojie Liu,
  • Beibei Lei,
  • Ming Wang,
  • Liangsheng Chen,
  • Heling Wang,
  • Di Zhang,
  • Shenhong Ma,
  • Qiaohua Han,
  • Shaowen Liu,
  • Jiayin Yang,
  • Weisheng Zhuang

摘要

Objective

This study aimed to investigate the efficacy of repetitive transcranial magnetic stimulation (rTMS) for improving spasticity, motor function, and activities of daily living (ADL) in patients with post-stroke spasticity (PSS), and to perform a comprehensive analysis of key factors related to its therapeutic effect.

Methods

Relevant randomized controlled trials (RCTs) were retrieved from four databases. Meta-analysis was conducted using RevMan, and the quality of evidence was assessed with the GRADEpro tool.

Results

Overall, 13 studies (encompassing 18 RCTs) were included. The results demonstrated that rTMS alleviated PSS (MD = − 0.23, 95% CI: −0.43 to − 0.02, P = 0.03) and improved motor (MD = 2.46, 95% CI: 1.54 to 3.38, P < 0.00001), whereas it showed no significant effect on ADL (SMD = 0.31, 95% CI: -0.06 to 0.67, P = 0.10). For spasticity, stimulating the unaffected hemisphere achieved significantly better efficacy (SMD = -0.19, 95% CI: -0.37 to -0.00, P = 0.05), and combined high and low frequency rTMS showed promising effects (SMD = -0.65, 95% CI: -0.94 to -0.36, P < 0.00001). For motor function, rTMS yielded greater improvement in upper limb PSS patients (SMD = 3.58, 95% CI: 2.18 to 4.98, P < 0.00001). Within a certain range, pulse number was positively correlated with motor improvement (β = 2.46, 95% CI: 0.097 to 4.81, P = 0.043).

Conclusion

Moderate to high quality evidence demonstrates that rTMS can potentially alleviate PSS and improve motor function in patients, whereas its efficacy in improving ADL remains unclear, with very low quality of evidence. In addition, stimulation frequency, stimulation site, pulse number, and affected site are key moderators of rTMS efficacy. These findings guide the clinical optimization of rTMS regimens, and future research is required to identify specific parameter thresholds.